ClinicalTrials.gov
ClinicalTrials.gov Menu

A Clinical Trial of ADI-PEG 20TM in Patients With Malignant Pleural Mesothelioma (ADAM)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01279967
Recruitment Status : Unknown
Verified May 2012 by Barts & The London NHS Trust.
Recruitment status was:  Active, not recruiting
First Posted : January 20, 2011
Last Update Posted : November 20, 2014
Sponsor:
Collaborators:
Cancer Research UK
UK: Barts Center for Experimental Cancer Medicine (CECM) for Trial Coordination
Information provided by (Responsible Party):
Barts & The London NHS Trust

Results Submitted - Not Posted on ClinicalTrials.gov
Results information has been submitted to ClinicalTrials.gov by the sponsor or investigator, but is not yet publicly available (or "posted") on ClinicalTrials.gov. The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
  Recruitment Status : Unknown
  Estimated Primary Completion Date : January 2015
  Estimated Study Completion Date : March 2015

Submission Cycle Results Submitted to ClinicalTrials.gov Results Returned after Quality Control Review
1 August 30, 2017
March 29, 2018
Publications:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):